| Ident. | Authors (with country if any) | Title |
|---|
| 000104 (2000) |
K. Ancolio ; C. Alves Da Costa ; K. Ueda ; F. Checler | α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells |
| 000130 (2000) |
Wakako Maruyama ; Kumiko Sango ; Kinuko Iwasa ; Chiyoko Minami ; Philippe Dostert ; Masao Kawai ; Masataka Moriyasu ; Makoto Naoi | Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4')-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells : apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines |
| 000164 (2000) |
Makoto Naoi ; Wakako Maruyama ; Yukihito Akao ; JIN ZHANG ; Hasan Parvez | Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons |
| 000176 (2001) |
W. Maruyama ; A. A. Boulton ; B. A. Davis ; P. Dostert ; M. Naoi | Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine |
| 000324 (2002) |
Hidehiro Hirabayashi ; Magnus Tengvar ; Marwan I. Hariz | Stereotactic imaging of the pallidal target |
| 000403 (2002) |
Toshiharu Nagatsu | Amine-related neurotoxins in Parkinson's disease: Past, present, and future |
| 000405 (2002) |
Wakako Maruyama ; Yukihiro Akao ; Maria Chrisina Carrillo ; Ken-Ichi Kitani ; Moussa B. H. Youdium ; Makoto Naoi | Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes |
| 000407 (2002) |
Makoto Naoi ; Wakako Maruyama ; Yukihiro Akao ; HONG YI | Dopamine-derived endogenous N-methyl-(R)-salsolinol its role in Parkinson's disease |
| 000411 (2002) |
Kazuo Matsubara ; Koji Aoyama ; Manabu Suno ; Toshio Awaya | N-methylation underlying Parkinson's disease |
| 000412 (2002) |
Yoko Hirata | Manganese-induced apoptosis in PC12 cells |
| 000413 (2002) |
Yoshimi Misu ; Nobuya Furukawa ; Nobutaka Arai ; Takeaki Miyamae ; Yoshio Goshima ; Kiyohide Fujita | DOPA causes glutamate release and delayed neuron death by brain ischemia in rats |
| 000587 (2004) |
Mitsuhiko Yamada ; Hajime Yasuhara | Clinical pharmacology of MAO inhibitors: Safety and future |
| 000588 (2004) |
Makoto Naoi ; Wakako Maruyama ; Georgy M. Nagy | Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains |
| 000594 (2004) |
N. Hamaue ; M. Minami ; M. Terado ; M. Hirafuji ; T. Endo ; M. Machida ; T. Hiroshige ; A. Ogata ; K. Tashiro ; H. Saito ; S. H. Parvez | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
| 000596 (2004) |
Toshiharu Nagatsu | Progress in monoamine oxidase (MAO) research in relation to genetic engineering |
| 000603 (2004) |
Demetrius M. Maraganore ; Timothy G. Lesnick ; Alexis Elbaz ; Marie-Christine Chartier-Harlin ; Thomas Gasser ; Rejko Krüger ; Nobutaka Hattori ; George D. Mellick ; Aldo Quattrone ; Jun-Ichi Satoh ; Taksushi Toda ; JIAN WANG ; John P. A. Ioannidis ; Mariza De Andrade ; Walter A. Rocca | UCHL1 is a Parkinson's disease susceptibility gene |
| 000679 (2004) |
C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio Stocchi | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 000821 (2005) |
I. G. Mckeith ; D. W. Dickson ; J. Lowe ; M. Emre ; J. T. O'Brien ; H. Feldman ; J. Cummings ; J. E. Duda ; C. Lippa ; E. K. Perry ; D. Aarsland ; H. Arai ; C. G. Ballard ; B. Boeve ; D. J. Burn ; D. Costa ; T. Del Ser ; B. Duboi ; D. Galasko ; S. Gauthier ; C. G. Goetz ; E. Gomez-Tortos ; F. G. Halliday ; L. A. Hansen ; J. Hardy ; T. Iwatsubo ; R. N. Kalaria ; D. Kaufer ; R. A. Kenny ; A. Korczyn ; K. Kosaka ; V. M.-Y. Lee ; A. Lees ; I. Litvan ; E. Londos ; O. L. Lopez ; S. Minoshima ; Y. Mizuno ; J. A. Molina ; E. B. Mukaetova-Ladinska ; F. Pasquier ; R. H. Perry ; J. B. Schulz ; J. Q. Trojanowski ; M. Yamada | Diagnosis and management of dementia with lewy bodies : Third report of the DLB consortium |
| 000882 (2006) |
A.-M. Shiarli ; R. Jennings ; J. Shi ; K. Bailey ; Y. Davidson ; J. Tian ; E. H. Bigio ; B. Ghetti ; J. R. Murrell ; M. B. Delisle ; S. Mirra ; B. Crain ; P. Zolo ; K. Arima ; E. Iseki ; S. Murayama ; H. Kretzschmar ; M. Neumann ; C. Lippa ; G. Halliday ; J. Mackenzie ; N. Khan ; R. Ravid ; D. Dickson ; Z. Wszolek ; T. Iwatsubo ; S. M. Pickering-Brown ; D. M. A. Mann | Comparison of extent of tau pathology in patients with frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease |
| 000905 (2006) |
Lianna Ishihara ; Liling Warren ; Rachel Gibson ; Rim Amouri ; Suzanne Lesage ; Alexandra Durr ; Meriem Tazir ; Zbigniew K. Wszolek ; Ryan J. Uitti ; William C. Nichols ; Alida Griffith ; Nobutaka Hattori ; David Leppert ; Ray Watts ; Cyrus P. Zabetian ; Tatiana M. Foroud ; Matthew J. Farrer ; Alexis Brice ; Lefkos Middleton ; Faycal Hentati | Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations |
| 000975 (2007) |
C. F. Lippa ; J. E. Duda ; M. Grossman ; H. I. Hurtig ; D. Aarsland ; B. F. Boeve ; D. J. Brooks ; D. W. Dickson ; B. Dubois ; M. Emre ; S. Fahn ; J. M. Farmer ; D. Galasko ; J. E. Galvin ; C. G. Goetz ; J. H. Growdon ; K. A. Gwinn-Hardy ; J. Hardy ; P. Heutink ; T. Iwatsubo ; K. Kosaka ; V. M.-Y. Lee ; J. B. Leverenz ; E. Masliah ; I. G. Mckeith ; R. L. Nussbaum ; C. W. Olanow ; B. M. Ravina ; A. B. Singleton ; C. M. Tanner ; J. Q. Trojanowski ; Z. K. Wszolek | DLB and PDD boundary issues : Diagnosis, treatment, molecular pathology, and biomarkers |
